Literature DB >> 28859533

Comparison of bolus versus continuous infusion of propofol for procedural sedation: a meta-analysis.

Geun Joo Choi1, Hyun Kang1, Chong Wha Baek1, Yong Hun Jung1, Je Jin Lee1.   

Abstract

OBJECTIVE: To compare the efficacy and safety of bolus infusion versus continuous infusion for propofol sedation.
METHODS: We searched OVID-MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar, Koreamed, and Kmbase databases to identify all randomized controlled trials that compared bolus infusion with continuous infusion for propofol sedation. We evaluated propofol dose used, procedure, sedation, and recovery time. The incidences of respiratory and cardiovascular complications were also evaluated.
RESULTS: A total of 12 studies of 963 patients were included. The required propofol dose was significantly higher in continuous infusion compared with bolus infusion (standardized mean difference [SMD]: -0.44; 95% confidence interval [CI]: -0.71 to -0.16; I2 = 84%). Sedation time was significantly longer in continuous infusion compared with bolus infusion (mean difference [MD]: -8.58 min; 95% CI: -15.13 to -2.03; I2 = 44%). The recovery time and incidences of desaturation, airway intervention, hypotension, and bradycardia were comparable between bolus and continuous infusion.
CONCLUSIONS: Propofol sedation by continuous infusion required a higher dose of propofol compared with bolus infusion, but the recovery time and frequency of complications were similar.

Entities:  

Keywords:  Bolus infusion; continuous infusion; meta-analysis; propofol; sedation

Mesh:

Substances:

Year:  2017        PMID: 28859533     DOI: 10.1080/03007995.2017.1370419

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  1 in total

1.  Continuous infusion versus intermittent bolus injection of propofol during endoscopic retrograde cholangiopancreatography.

Authors:  Jae Gon Lee; Kyo-Sang Yoo; Young Jae Byun
Journal:  Korean J Intern Med       Date:  2020-03-05       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.